About
Alan Tomusiak is a longevity and cancer-prevention entrepreneur and researcher. He is founder and CEO of Permanence Bio, and his academic work spans the Buck Institute for Research on Aging and USC, with publications on epigenetic clocks, immune aging, and biomarkers of aging. Public web evidence also associates him with age1 as a principal, linking him to early-stage longevity investing.
Areas of interest
longevitybiotechcancer preventionaging biomarkersepigenetic clocksimmune aginggenome stabilitytherapeutics